E5: WHO's incompetence, kicking off Cold War II, China's grand plan, 100X'ing American efficiency

Friedberg argued Bayer’s looming Roundup liability stemmed from a politicized WHO/IARC process, not settled science. He said he vetted glyphosate before selling Climate.com to Monsanto, claimed IARC excluded contrary studies, and estimated the resulting lawsuits would cost Bayer $10–15 billion.

Friedberg’s strongest example of Chinese industrial strategy came from Monsanto’s failed Syngenta bid. Monsanto offered about $44 billion, ChemChina won at roughly $47 billion, and Friedberg tied the broader buying spree to a 2007 CCP agricultural policy that supplied capital and strategic direction without dictating each transaction.

The panel treated semiconductors—not TikTok—as the more consequential U.S.-China pressure point. They highlighted Taiwan’s concentration of advanced chip fabrication and framed U.S. restrictions on Huawei’s access to TSMC as exposing a strategic dependency that would require years and major capital to unwind.

Chamath’s answer to China’s manufacturing scale was an Americas-wide production bloc, not U.S. autarky. The speakers cited 2.8 million Chinese factories and 83 million factory workers versus 250,000 and 12 million in America, while Friedberg argued competition with China still requires international partners.

Calacanis described a doxxing episode that moved an online feud into his home life. He said a man reverse-image-searched a photo of his treeline to find and publish his address, then removed it and apologized after Calacanis traced professional connections to the man’s boss and confronted him directly.

Friedberg’s most concrete technology thesis was that programmable microbes could turn fermentation tanks into flexible factories for food, pharma and materials. He said biomanufacturing can cut energy and production costs by orders of magnitude, pointing to Perfect Day’s $300 million and Impossible Foods’ $400 million raises as evidence capital was already moving.